APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

13 hedge funds and large institutions have $26.5M invested in Aptevo Therapeutics in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.34M
2
+$1.63M
3
+$813K

Top Sellers

1
-$1.27M
2
-$881K
3
-$877K
4
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$818K
5
Morgan Stanley
Morgan Stanley
New York
-$665K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$148K
27
$129K
28
$122K
29
$120K
30
$118K
31
$106K
32
$106K
33
$94K
34
$90K
35
$83K
36
$74K
37
$63K
38
$56K
39
$55K
40
$54K
41
$50K
42
$49K
43
$47K
44
$45K
45
$41K
46
$40K
47
$37K
48
$35K
49
$35K
50
$33K
1
2
3 4 5